Minimal residual disease (MRD) Tumor Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Checkpoint inhibitor Maintenance chemotherapy Adenocarcinoma Adjuvant treatment leukemia Relapse Active surveillance Clinical stage Carcinoma Chemotherapy Surgical margin Complementary therapy Recurrence Pathological stage Cure Complete remission Palliation performance status Neoadjuvant treatment CTACAE Sarcoma Monoclonal antibody Antibody Drug Conjugate (ADCs) Definitive treatment ECOG performance status TNM staging system Partial Remission Refractory Grade 3, 4, or 5 Cellular therapy Minimal residual disease (MRD) Tumor Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Checkpoint inhibitor Maintenance chemotherapy Adenocarcinoma Adjuvant treatment leukemia Relapse Active surveillance Clinical stage Carcinoma Chemotherapy Surgical margin Complementary therapy Recurrence Pathological stage Cure Complete remission Palliation performance status Neoadjuvant treatment CTACAE Sarcoma Monoclonal antibody Antibody Drug Conjugate (ADCs) Definitive treatment ECOG performance status TNM staging system Partial Remission Refractory Grade 3, 4, or 5 Cellular therapy
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Minimal residual disease (MRD)
Tumor
Tyrosine kinase inhibitors (TKIs)
Maintenance chemotherapy
Checkpoint inhibitor
Maintenance chemotherapy
Adenocarcinoma
Adjuvant treatment
leukemia
Relapse
Active surveillance
Clinical stage
Carcinoma
Chemotherapy
Surgical margin
Complementary therapy
Recurrence
Pathological stage
Cure
Complete remission
Palliation
performance status
Neoadjuvant treatment
CTACAE
Sarcoma
Monoclonal antibody
Antibody Drug Conjugate (ADCs)
Definitive treatment
ECOG performance status
TNM staging system
Partial Remission
Refractory
Grade 3, 4, or 5
Cellular therapy